Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
New England Biolabs NEB today announced the launch of the NEBNext Lowbias Small RNA Library Prep Kit designed to minimize biased representation of small RNA species in sequencing data
RedHill Biopharma Ltda specialty biopharmaceutical company today announced that it received positive feedback from the US Food and Drug Administration FDA following a scheduled Type C meeting
Orions collaboration partner Bayer announced today that the European Commission has granted marketing authorization in the European Union EU for darolutamide an oral androgen receptor inhibitor ARi plus androgen deprivation therapy ADT for the treatm...
Yingen Biopharma announced that the US Food and Drug Administration FDA has granted Yingen Biopharmas nextgeneration HER ADC DB Fast Track Designation FTD for the treatment of adult patients with advancedunresectable or metastatic non squamous n...
WuXi Biologics HK a leading global Contract Research Development and Manufacturing Organization CRDMO announced that five manufacturing facilities successfully passed the PreLicense Inspection
Curocell a CART treatment specialist successfully built CUROLINK an integrated solution that tracks and manages the entire process from prescription to administration in real time ahead of the commercialization of the nextgeneration CART treatment RI...
AstraZeneca today announces billion of investment in the United States by building on Americas global leadership in medicines manufacturing and RD This investment is expected to create tens of thousands
Biogen Inc today announced it intends to invest an additional billion in its existing manufacturing footprint in North Carolinas Research Triangle Park RTP Since breaking ground in Biogens manufacturing in RTP has played
EQT a leading global investment firm with a strong track record of owning and developing healthcare companies around the world today announced that it has signed a definitive agreement to acquire a majority stake in Adalvo
ARS Pharmaceuticals Inca biopharmaceutical company dedicated to empowering atrisk patients and their caregivers to better protect themselves from allergic reactions that could lead to anaphylaxis announced today that the United Kingdom
